The drug ACI-JEL contains a combination of these active pharmaceutical ingredients (APIs):
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: Australia New Zealand
This drug has been assigned below unique identifiers within the countries it is being marketed: